NOVOZYMES A/S: cashflow_financing

Value{"amount": -456000000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}
Period2023-04-01 – 2023-06-30
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2023-06-30
Retrieved: 2026-08-24T00:28:49.891731+02:00
Raw response sha256: 7c6db7831ffb121626f5a6c63c65c888…
Cite as: FACTANKER, https://factanker.com/fact/f9341dfd-cfee-448e-a58b-dbfcda8a7fda

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies